Prospective intrapatient Comparison of MRI-based risk models, intraoperative Cerenkov luminescence imaging and printed 3D-models to detect extracapsular extension in intermediate- and high-risk prostate cancer

Not Applicable

• Conditions: C61; Malignant neoplasm of prostate

• Registration Number: DRKS00025059
• Lead Sponsor: niversitätsklinikum Essen

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2021-05-03
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Pending
• Sex: Male
• Target Recruitment: 15

Inclusion Criteria

Indication for radical prostatectomy, intermediate- and high-risk prostate cancer

Exclusion Criteria

low-risk prostate cancer

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Rate of correct predicted extracapsular tumor extension in percent

Secondary Outcome Measures

Name	Time	Method
Reduction of positive surgical margins